175 filings
Page 2 of 9
8-K
90qiwzsj
15 Jun 21
AtriCure Names Two New Members to the Board of Directors
7:02am
8-K
w2uuyn36
24 May 21
Submission of Matters to a Vote of Security Holders
4:16pm
8-K
orkphdnjfjqcaqhkwtk
29 Apr 21
AtriCure’s EPi-Sense System Approved by FDA
7:00am
8-K
rswhovmdb1p6ce mqhh
27 Apr 21
AtriCure Reports First Quarter 2021 Financial Results
4:00pm
8-K
0vauxxxv2dx
8 Apr 21
AtriCure Names B. Kristine Johnson Board Chair
8:00am
8-K
q9xgmi96sss
23 Feb 21
AtriCure Reports Fourth Quarter 2020 and Full Year 2020 Financial Results
4:01pm
8-K
2gqce gout0ix965d4
11 Jan 21
AtriCure Reports Preliminary Results for Fourth Quarter and Full Year 2020
7:00am
8-K
na4dpy7
5 Nov 20
AtriCure Reports Third Quarter 2020 Financial Results
4:07pm
8-K
72w2n4k4
6 Aug 20
AtriCure Announces Angie Wirick as Chief Financial Officer
4:16pm
8-K
5fpyglf3
28 Jul 20
AtriCure Reports Second Quarter 2020 Financial Results
4:03pm
8-K
2wkqwe
22 May 20
Departure of Directors or Certain Officers
11:46am
8-K
2axu7jqe6ftnwq7lpe6z
13 May 20
AtriCure Announces Proposed Public Offering of Common Stock
12:00am
8-K
dp8rvf15y7kxqjyx
8 May 20
AtriCure Announces Results from CONVERGE IDE Clinical Trial
8:55am
8-K
zz94 gi2rga9hwjc
29 Apr 20
AtriCure Reports First Quarter 2020 Financial Results
4:05pm
8-K
7ld7u
13 Apr 20
AtriCure Announces CONVERGE IDE Trial Results Accepted for Late-Breaking Clinical Trial Sessions at Annual Heart Rhythm Society (HRS) Meeting
8:00am
8-K
czwojgx
9 Apr 20
AtriCure Announces Preliminary Financial Results for First Quarter 2020 and Provides COVID-19 Pandemic Update
8:00am
8-K
svsa20i40 4qjb
18 Feb 20
AtriCure Reports Fourth Quarter 2019 and Full Year 2019 Financial Results
4:08pm
8-K
b5hr3ewme4e
13 Jan 20
AtriCure Reports Preliminary Results for Fourth Quarter and Full Year 2019
8:06am
8-K
wke jxyb9x
4 Dec 19
AtriCure Names Two Industry Veterans to Board of Directors
8:05am
8-K
fb5blq qjnjf
30 Oct 19
AtriCure Reports Third Quarter 2019 Financial Results
4:06pm